-
公开(公告)号:CA2032228A1
公开(公告)日:1991-06-23
申请号:CA2032228
申请日:1990-12-13
Applicant: ABBOTT LAB
Inventor: KOLACZKOWSKI LAWRENCE , LITTLEFIELD MARK
IPC: G01N33/52 , A61K49/00 , C07D227/00 , C07D493/10 , C07K14/435 , C07K14/76 , C07K14/765 , C09B11/08 , C09B11/28 , C09B29/12 , G01N33/53 , G01N33/533
Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y1 and Y2 is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens. 21
-
公开(公告)号:DE69012541T2
公开(公告)日:1995-03-23
申请号:DE69012541
申请日:1990-12-21
Applicant: ABBOTT LAB
Inventor: KOLACZKOWSKI LAWRENCE , LITTLEFIELD MARK
IPC: G01N33/52 , A61K49/00 , C07D227/00 , C07D493/10 , C07K14/435 , C07K14/76 , C07K14/765 , C09B11/08 , C09B11/28 , C09B29/12 , G01N33/53 , G01N33/533
Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y and Y is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens.
-
公开(公告)号:ES2063890T3
公开(公告)日:1995-01-16
申请号:ES90125063
申请日:1990-12-21
Applicant: ABBOTT LAB
Inventor: KOLACZKOWSKI LAWRENCE , LITTLEFIELD MARK
IPC: G01N33/52 , A61K49/00 , C07D227/00 , C07D493/10 , C07K14/435 , C07K14/76 , C07K14/765 , C09B11/08 , C09B11/28 , C09B29/12 , G01N33/53 , C07K15/06 , G01N33/533
Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y and Y is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens.
-
公开(公告)号:DE69012541D1
公开(公告)日:1994-10-20
申请号:DE69012541
申请日:1990-12-21
Applicant: ABBOTT LAB
Inventor: KOLACZKOWSKI LAWRENCE , LITTLEFIELD MARK
IPC: G01N33/52 , A61K49/00 , C07D227/00 , C07D493/10 , C07K14/435 , C07K14/76 , C07K14/765 , C09B11/08 , C09B11/28 , C09B29/12 , G01N33/53 , C07K15/06 , G01N33/533
Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y and Y is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens.
-
公开(公告)号:AT111489T
公开(公告)日:1994-09-15
申请号:AT90125063
申请日:1990-12-21
Applicant: ABBOTT LAB
Inventor: KOLACZKOWSKI LAWRENCE , LITTLEFIELD MARK
IPC: G01N33/52 , A61K49/00 , C07D227/00 , C07D493/10 , C07K14/435 , C07K14/76 , C07K14/765 , C09B11/08 , C09B11/28 , C09B29/12 , G01N33/53 , C07K15/06 , G01N33/533
Abstract: A substituted monoethylglycinexylidide or analogue is disclosed. The xylidide or analogue has the structure of Fig. 1 of the attached drawings where M is CH2NHCH2CH3, CH2CH2CH2CH3 or CH2OCH2CH3, one of Y and Y is H and the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Also disclosed is a method for carrying out immunoassays for MEGX, which has the structure of Fig. 3 of the attached drawings. The method for carrying out immunoassays involves using the foregoing compounds as tracers and immunogens.
-
-
-
-